Effects of antidepressant medicines on preventing relapse of unipolar depression: a pooled analysis of parametric survival curves.
Saved in:
| Title: | Effects of antidepressant medicines on preventing relapse of unipolar depression: a pooled analysis of parametric survival curves. |
|---|---|
| Authors: | Zhou, Dongdong, Lv, Zhen, Shi, Lei, Zhou, Xiaoxin, Lin, Qingxia, Chen, Xiaorong, Wan, Liyang, Li, Yao, Ran, Liuyi, Huang, Yan, Wang, Gaomao, Li, Daqi, Wang, Wo, Liu, Chuan, Kuang, Li |
| Source: | Psychological Medicine. Jan2022, Vol. 52 Issue 1, p48-56. 9p. |
| Subjects: | Prevention of mental depression, Disease relapse prevention, Antidepressants, Statistics, Patient aftercare, Experimental design, Randomized controlled trials, Placebos, Descriptive statistics, Data analysis, Probability theory |
| Abstract: | Background: Major depressive disorder is characterized by a high risk of relapse. We aimed to compare the prophylactic effects of different antidepressant medicines (ADMs). Methods: PubMed, Cochrane Central Register of Controlled Trials, Embase and the Web of Science were searched on 4 July 2019. A pooled analysis of parametric survival curves was performed using a Bayesian framework. The main outcomes were hazard ratios (HRs), relapse-free survival and mean relapse-free months. Results: Forty randomized controlled trials were included. The 1-year relapse-free survival for ADM (76%) was significantly better than that for placebo (56%). Most of the relapse difference (86.5%) occurred in the first 6 months. Most HRs were not constant over time. Proof of benefit after 6 months of follow-up was not established partially because of small differences between the drug and placebo after 6 months. Almost all studies used an 'enriched' randomized discontinuation design, which may explain the high relapse rates in the first 6 months after randomization. Conclusions: The superiority of ADM v. placebo was mainly attributed to the difference in relapse rates that occurred in the first 6 months. Our analysis provided evidence that the prophylactic efficacy was not constant over time. A beneficial effect was observed, but the prevention of new episodes after 6 months was questionable. These findings may have implications for clinical practice. [ABSTRACT FROM AUTHOR] |
| Copyright of Psychological Medicine is the property of Cambridge University Press and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) | |
| Database: | Psychology and Behavioral Sciences Collection |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: pbh DbLabel: Psychology and Behavioral Sciences Collection An: 154311168 AccessLevel: 6 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Effects of antidepressant medicines on preventing relapse of unipolar depression: a pooled analysis of parametric survival curves. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Zhou%2C+Dongdong%22">Zhou, Dongdong</searchLink><br /><searchLink fieldCode="AR" term="%22Lv%2C+Zhen%22">Lv, Zhen</searchLink><br /><searchLink fieldCode="AR" term="%22Shi%2C+Lei%22">Shi, Lei</searchLink><br /><searchLink fieldCode="AR" term="%22Zhou%2C+Xiaoxin%22">Zhou, Xiaoxin</searchLink><br /><searchLink fieldCode="AR" term="%22Lin%2C+Qingxia%22">Lin, Qingxia</searchLink><br /><searchLink fieldCode="AR" term="%22Chen%2C+Xiaorong%22">Chen, Xiaorong</searchLink><br /><searchLink fieldCode="AR" term="%22Wan%2C+Liyang%22">Wan, Liyang</searchLink><br /><searchLink fieldCode="AR" term="%22Li%2C+Yao%22">Li, Yao</searchLink><br /><searchLink fieldCode="AR" term="%22Ran%2C+Liuyi%22">Ran, Liuyi</searchLink><br /><searchLink fieldCode="AR" term="%22Huang%2C+Yan%22">Huang, Yan</searchLink><br /><searchLink fieldCode="AR" term="%22Wang%2C+Gaomao%22">Wang, Gaomao</searchLink><br /><searchLink fieldCode="AR" term="%22Li%2C+Daqi%22">Li, Daqi</searchLink><br /><searchLink fieldCode="AR" term="%22Wang%2C+Wo%22">Wang, Wo</searchLink><br /><searchLink fieldCode="AR" term="%22Liu%2C+Chuan%22">Liu, Chuan</searchLink><br /><searchLink fieldCode="AR" term="%22Kuang%2C+Li%22">Kuang, Li</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Psychological+Medicine%22">Psychological Medicine</searchLink>. Jan2022, Vol. 52 Issue 1, p48-56. 9p. – Name: Subject Label: Subjects Group: Su Data: <searchLink fieldCode="DE" term="%22Prevention+of+mental+depression%22">Prevention of mental depression</searchLink><br /><searchLink fieldCode="DE" term="%22Disease+relapse+prevention%22">Disease relapse prevention</searchLink><br /><searchLink fieldCode="DE" term="%22Antidepressants%22">Antidepressants</searchLink><br /><searchLink fieldCode="DE" term="%22Statistics%22">Statistics</searchLink><br /><searchLink fieldCode="DE" term="%22Patient+aftercare%22">Patient aftercare</searchLink><br /><searchLink fieldCode="DE" term="%22Experimental+design%22">Experimental design</searchLink><br /><searchLink fieldCode="DE" term="%22Randomized+controlled+trials%22">Randomized controlled trials</searchLink><br /><searchLink fieldCode="DE" term="%22Placebos%22">Placebos</searchLink><br /><searchLink fieldCode="DE" term="%22Descriptive+statistics%22">Descriptive statistics</searchLink><br /><searchLink fieldCode="DE" term="%22Data+analysis%22">Data analysis</searchLink><br /><searchLink fieldCode="DE" term="%22Probability+theory%22">Probability theory</searchLink> – Name: Abstract Label: Abstract Group: Ab Data: Background: Major depressive disorder is characterized by a high risk of relapse. We aimed to compare the prophylactic effects of different antidepressant medicines (ADMs). Methods: PubMed, Cochrane Central Register of Controlled Trials, Embase and the Web of Science were searched on 4 July 2019. A pooled analysis of parametric survival curves was performed using a Bayesian framework. The main outcomes were hazard ratios (HRs), relapse-free survival and mean relapse-free months. Results: Forty randomized controlled trials were included. The 1-year relapse-free survival for ADM (76%) was significantly better than that for placebo (56%). Most of the relapse difference (86.5%) occurred in the first 6 months. Most HRs were not constant over time. Proof of benefit after 6 months of follow-up was not established partially because of small differences between the drug and placebo after 6 months. Almost all studies used an 'enriched' randomized discontinuation design, which may explain the high relapse rates in the first 6 months after randomization. Conclusions: The superiority of ADM v. placebo was mainly attributed to the difference in relapse rates that occurred in the first 6 months. Our analysis provided evidence that the prophylactic efficacy was not constant over time. A beneficial effect was observed, but the prevention of new episodes after 6 months was questionable. These findings may have implications for clinical practice. [ABSTRACT FROM AUTHOR] – Name: AbstractSuppliedCopyright Label: Group: Ab Data: <i>Copyright of Psychological Medicine is the property of Cambridge University Press and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.</i> (Copyright applies to all Abstracts.) |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=pbh&AN=154311168 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1017/S0033291720001610 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 9 StartPage: 48 Subjects: – SubjectFull: Prevention of mental depression Type: general – SubjectFull: Disease relapse prevention Type: general – SubjectFull: Antidepressants Type: general – SubjectFull: Statistics Type: general – SubjectFull: Patient aftercare Type: general – SubjectFull: Experimental design Type: general – SubjectFull: Randomized controlled trials Type: general – SubjectFull: Placebos Type: general – SubjectFull: Descriptive statistics Type: general – SubjectFull: Data analysis Type: general – SubjectFull: Probability theory Type: general Titles: – TitleFull: Effects of antidepressant medicines on preventing relapse of unipolar depression: a pooled analysis of parametric survival curves. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Zhou, Dongdong – PersonEntity: Name: NameFull: Lv, Zhen – PersonEntity: Name: NameFull: Shi, Lei – PersonEntity: Name: NameFull: Zhou, Xiaoxin – PersonEntity: Name: NameFull: Lin, Qingxia – PersonEntity: Name: NameFull: Chen, Xiaorong – PersonEntity: Name: NameFull: Wan, Liyang – PersonEntity: Name: NameFull: Li, Yao – PersonEntity: Name: NameFull: Ran, Liuyi – PersonEntity: Name: NameFull: Huang, Yan – PersonEntity: Name: NameFull: Wang, Gaomao – PersonEntity: Name: NameFull: Li, Daqi – PersonEntity: Name: NameFull: Wang, Wo – PersonEntity: Name: NameFull: Liu, Chuan – PersonEntity: Name: NameFull: Kuang, Li IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 01 Text: Jan2022 Type: published Y: 2022 Identifiers: – Type: issn-print Value: 00332917 Numbering: – Type: volume Value: 52 – Type: issue Value: 1 Titles: – TitleFull: Psychological Medicine Type: main |
| ResultId | 1 |